SCHEMBL7986139

SCHEMBL7986139

CC(C)(C)OC(=O)N1CCC(C(=O)/C=C/C2=Cc3cnc4cccc(n34)S2)CC1

nearest known ligand 0.39

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.39
STS P08842 2/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
KMT2A Q03164 1/20 0.38
HPGD P15428 1/20 0.37
NAMPT P43490 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985595 1.00 GPR119 (0.39) GPR119STSPTPN2PTPN1PTPN6
SCHEMBL7983171 0.87 FAAH (0.40) GPR119NAMPT
SCHEMBL7983168 0.87 FAAH (0.40) GPR119NAMPT
SCHEMBL7989477 0.86 KDM4E (0.47) GPR119NAMPT
SCHEMBL7989480 0.86 KDM4E (0.47) GPR119NAMPT
SCHEMBL7973179 0.83 GPR119 (0.39) GPR119STS
SCHEMBL7973184 0.83 GPR119 (0.39) GPR119STS
SCHEMBL7987858 0.81 TGFBR1 (0.44)
SCHEMBL7987855 0.81 TGFBR1 (0.44)
Hydrochloric Acid SCHEMBL7971644 0.80 IRAK4 (0.30) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235731-B1 REDUCING BLOOD LIPIDS, SUGARS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-05-22 US disclosed
EP-0915888-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS Takeda Chemical Industries, Ltd. (JP) 1999-05-19 EP disclosed
WO-1997040051-A1 FUSED IMIDAZOPYRIDINE DERIVATIVES AS ANTIHYPERLIPIDEMIC AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-10-30 WO disclosed